CoChat

Free hemoglobin concentration in severe sepsis: methods of measurement and prediction of outcome

Open access
Adamzik, Michael, Hamburger, Tim, Petrat, Frank, Peters, Jürgen, de Groot, Herbert, Hartmann, Matthias · 2012 · Critical Care

The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index; 6 of the 37 sources its claims cite were checked for support.

Abstract

Introduction: Hemolysis can be induced in sepsis via various mechanisms, its pathophysiological importance has been demonstrated in experimental sepsis. However, no data on free hemoglobin concentrations in human sepsis are available. In the present study we measured free hemoglobin in patients with severe sepsis as well as in postoperative patients using four methods. It was our aim to determine the potential value of free hemoglobin as a biomarker for diagnosis and outcome of severe sepsis in critical illness. Methods: Plasma concentration of free hemoglobin was determined in patients with severe sepsis ( n = 161) and postoperative patients ( n = 136) on day 1 of diagnosis and surgery. For the measurement of free hemoglobin, an enzyme linked immunosorbent assay and three spectrophotometric algorithms were used. Moreover, SAPS II- and SOFA scores as well as procalcitonin concentration and outcome were determined. Kaplan-Meier analysis was performed and odds ratios were determined after classification of free hemoglobin concentrations in a high and low concentration group according to the median. For statistical evaluation the Mann-Whitney test and logistic regression analysis were used. Results: In non-survivors of severe sepsis, free hemoglobin concentration was twice the concentration compared to survivors. Thirty-day survival of patients, as evidenced by Kaplan-Meier analysis, was markedly lower in patients with high free hemoglobin concentration than in patients with low free hemoglobin concentration. Best discrimination of outcome was achieved with the spectrophotometric method of Harboe (51.3% vs. 86.4% survival, p < 0.001; odds ratio 6.1). Multivariate analysis including free hemoglobin, age, SAPS II- and SOFA-score and procalcitonin demonstrated that free hemoglobin, as determined by all 4 methods, was the best and an independent predictor for death in severe sepsis (p = 0.022 to p < 0.001). Free hemoglobin concentrations were not significantly different in postoperative and septic patients in three of four assays. Thus, free hemoglobin can not be used to diagnose severe sepsis in critical illness. Conclusions: Free hemoglobin is an important new predictor of survival in severe sepsis.

Overview

CoChat Summary

TL;DR

In severe sepsis, plasma free hemoglobin above the median on day 1 was associated with increased 30-day mortality and was an independent predictor of death, outperforming procalcitonin, SAPS II, and SOFA scores. However, free hemoglobin did not distinguish severe sepsis from postoperative critical illness.

Key findings

  • Among 161 patients with severe sepsis, 50 died within 30 days. Non-survivors had approximately twice the median free hemoglobin concentration of survivors by all four assays, for example Harboe 0.147 g/l vs. 0.057 g/l, Noe 0.185 g/l vs. 0.068 g/l, Fairbanks 0.100 g/l vs. 0.053 g/l, and ELISA 0.054 g/l vs. 0.034 g/l.
  • High free hemoglobin above the median was associated with lower 30-day survival. Best discrimination was with the Harboe method: 51.3% vs. 86.4% survival, p < 0.001; odds ratio 6.06 (95% CI 2.79–7.80). Other odds ratios were 2.33 for ELISA, 5.21 for Noe, and 3.92 for Fairbanks.
  • In multivariate analysis including age, SAPS II, SOFA, procalcitonin, and one free hemoglobin method at a time, free hemoglobin was the best and an independent predictor of death for all four methods (p = 0.022 to p < 0.001). In univariate analysis, SAPS II, SOFA, and procalcitonin were not statistically significant (p = 0.058, 0.058, and 0.351, respectively).
  • Free hemoglobin did not diagnose severe sepsis: concentrations were not significantly different between postoperative and septic patients in three of four assays, and healthy probands also did not differ significantly from postoperative or septic patients.

Methods

  • Over two years, the study included 161 ICU patients with severe sepsis, 136 postoperative ICU patients without sepsis, and 9 healthy probands. Plasma from EDTA blood was obtained on day 1 of diagnosis or surgery, centrifuged within 2 hours, and stored at −70°C.
  • Free hemoglobin was measured by a commercial ELISA and three spectrophotometric algorithms: Harboe, Noe, and Fairbanks. SAPS II, SOFA, procalcitonin, packed red blood cell transfusions, and 30-day survival were also determined.
  • Statistical analysis used Mann-Whitney tests, Spearman-Rho correlations, Kaplan-Meier curves with log-rank tests, odds ratios with chi-square tests, and logistic regression with backward elimination including age, SAPS II, SOFA, procalcitonin, and one free hemoglobin method at a time.

Limitations

  • The paper states that an observational study cannot prove causality between free hemoglobin and outcome in severe sepsis, and that further studies are needed to determine the best measurement method.
  • The paper notes that no standard method for free hemoglobin measurement has been established in sepsis, and that one significant transfusion correlation may reflect lack of correction for repeat measurements.
  • The text also makes evident that the study was single-center, the healthy proband group was very small (n = 9), and free hemoglobin did not discriminate sepsis from postoperative critical illness.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/cc11425

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Free hemoglobin concentrations in survivors and non-survivors of severe sepsis as obtained by ELISA and three spectrophotometric methods. Data are given in boxplots (median, quartile, minimum, maximum). For statistical evaluation the Mann-Whitney test was used. Spectrophotometric methods were the methods of Harboe [13], Noe [14] and Fairbanks [15].
Figure 1 Free hemoglobin concentrations in survivors and non-survivors of severe sepsis as obtained by ELISA and three spectrophotometric methods. Data are given in boxplots (median, quartile, minimum, maximum). For statistical evaluation the Mann-Whitney test was used. Spectrophotometric methods were the methods of Harboe [13], Noe [14] and Fairbanks [15].CC BY · PubMed Central
Figure 2 Kaplan-Meier analyses of 30-day survival of patients with severe sepsis demonstrating the effect of high and low free hemoglobin concentrations as determined by four methods. Four sets of Kaplan-Meier curves are shown, as analysis was performed with each of the four methods used for the determination of free hemoglobin. The continuous lines show the survival of patients with free hemoglobin concentrations lower than the median, and the dotted lines show the survival when free hemoglobin concentration was higher than the median of all patients with sepsis. Significance levels for the log rank test are given in the figure. Methods used to measure free hemoglobin were ELISA and the spectrophotometric methods of Harboe [13], Noe [14] and Fairbanks [15].
Figure 2 Kaplan-Meier analyses of 30-day survival of patients with severe sepsis demonstrating the effect of high and low free hemoglobin concentrations as determined by four methods. Four sets of Kaplan-Meier curves are shown, as analysis was performed with each of the four methods used for the determination of free hemoglobin. The continuous lines show the survival of patients with free hemoglobin concentrations lower than the median, and the dotted lines show the survival when free hemoglobin concentration was higher than the median of all patients with sepsis. Significance levels for the log rank test are given in the figure. Methods used to measure free hemoglobin were ELISA and the spectrophotometric methods of Harboe [13], Noe [14] and Fairbanks [15].CC BY · PubMed Central
Figure 3 Free hemoglobin measured in postoperative patients and patients with severe sepsis using four methods. Free hemoglobin did not differ in postoperative and septic patients using three of the four methods. Therefore, free hemoglobin cannot serve as a biomarker for the diagnosis of severe sepsis in critical illness. Data are given in boxplots (median, quartile, minimum, maximum). For statistical evaluation the Mann-Whitney test was used. Methods used to measure free hemoglobin were ELISA and the spectrophotometric methods of Harboe [13], Noe [14] and Fairbanks [15].
Figure 3 Free hemoglobin measured in postoperative patients and patients with severe sepsis using four methods. Free hemoglobin did not differ in postoperative and septic patients using three of the four methods. Therefore, free hemoglobin cannot serve as a biomarker for the diagnosis of severe sepsis in critical illness. Data are given in boxplots (median, quartile, minimum, maximum). For statistical evaluation the Mann-Whitney test was used. Methods used to measure free hemoglobin were ELISA and the spectrophotometric methods of Harboe [13], Noe [14] and Fairbanks [15].CC BY · PubMed Central

Verification

Claims the paper makes

5 Valid · 0 Not valid · 18 Not checked · 48 Own results and interpretations

38 more claims

Create a free account to see all 71 claims and to verify the 31 references still open.

See all claims — free account
  • It may state two separate claims as one. 16
  • Probably not a substantial claim. 16
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 38 references

Cited by

Metadata

Authors
Adamzik, M., Hamburger, T., Petrat, F., Peters, J., de Groot, H., & Hartmann, M.
Affiliations
Essen University Hospital (DE)
Corresponding author
Hartmann, Matthias
Venue
Critical Care
Published
2012-07-16
Volume
16
Issue
4
Pages
R125-R125
ISSN
1364-8535 (ISSN-L)
OpenAlex
W1991115314
Cited by
137
References
39
Citations by year
2026: 4 · 2025: 7 · 2024: 16 · 2023: 8 · 2022: 9 · 2021: 13 · 2020: 11 · 2019: 13 · 2018: 14 · 2017: 7 · 2016: 10 · 2015: 11 · 2014: 5 · 2013: 8 · 2012: 1
FWCI
5.96
Type
journal article
Language
en
Open access
Licence
Locations
  • Critical Care (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DuEPublico (University of Duisburg-Essen) (submittedVersion, cc-by)
  • Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
Keywords
free hemoglobin, severe sepsis, sepsis biomarkers, hemolysis, sepsis outcome prediction, 30-day survival, spectrophotometry, procalcitonin, SAPS II, SOFA score, postoperative patients
MeSH terms
Aged, Calcitonin, Enzyme-Linked Immunosorbent Assay, Female, Hemoglobins, Humans, Male, Middle Aged, Postoperative Period, Predictive Value of Tests, Prognosis, Protein Precursors, Risk Factors, Spectrophotometry, Biomarkers, Calcitonin Gene-Related Peptide, Survival Rate, Hospital Mortality, Erythrocyte Transfusion, Sepsis, Organ Dysfunction Scores

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.